Clinical study on Acupuncture treatment of Hypertension with Hyperactivity of liver-Yang

Phase 1

• Conditions: essential hypertension

• Registration Number: ITMCTR2000003813
• Lead Sponsor: Dongzhimen Hospital of Beijing University of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Aged 18 to 65 years old male and female;
2. In accordance with the diagnostic criteria of essential hypertension in the 2018 revised Chinese guidelines for the Prevention and treatment of Hypertension, patients with grade 1 and 2 low, moderate and high-risk hypertension have regularly taken less than 2 kinds of antihypertensive drugs for more than 2 months, and their blood pressure is stable at the normal high value without much fluctuation. The main object of study was (SBP >=130 mmHg, DBP >=80 mmHg);
3. meet the diagnostic standard of hyperactivity of liver-yang in hypertension;
4. They have not received acupuncture treatment in the past one month;
5. It has a correct understanding of the significance of the clinical research and has a good compliance with the observation and evaluation of the researchers;
6. The informed consent form was signed by the patient himself or by the immediate family members of the patient.

Exclusion Criteria

1. Secondary hypertension such as aldosteronism, pheochromocytoma, Cushing syndrome, pregnancy hypertension and so on;
2. Patients with other serious complications such as cardio-cerebral vessels, kidney, retina, peripheral blood vessels, diabetes, blood diseases, etc., which are not suitable for acupuncture treatment;
3. Patients with skin diseases and skin damage at the tested acupoints;
4. Women with mental illness or pregnancy or lactation;
5. Complicated with diagnosed epilepsy, obstructive sleep apnea hypopnea syndrome and so on;
6. Those who are participating in other clinical trials.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Ambulatory blood pressure monitoring;